ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1067

Incidence and Prevalence Of Systemic Lupus Erythematosus: A 2010 Nation-Wide Population-Based Study Using French National Administrative Databases

Laurent Arnaud1, Jean-Paul Fagot2, Michel Païta2, Alexis Mathian3, Anne Fagot-Campagna2 and Zahir Amoura4, 1Internal Medicine, Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France, 2Caisse Nationale d’Assurance Maladie des Travailleurs Salariés, Paris, France, 3Internal Medicine Dpt 2, Pitié-Salpêtrière Hospital, APHP, Paris, France, 4Hôpital Pitié-Salpêtrière, AP-HP, UPMC Univ Paris 06 & French National Reference Center For Systemic Lupus and Antiphospholipid Syndrome, Paris, France

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: administrative databases, Epidemiologic methods, population studies and systemic lupus erythematosus (SLE)

  • Tweet
  • Email
  • Print
Session Information

Title: Epidemiology and Health Services II & III

Session Type: Abstract Submissions (ACR)

Background/Purpose:

To date, only a small number of studies have examined the epidemiology of systemic lupus erythematosus (SLE) on a nation-wide basis. These studies were restricted to specific age groups and/or non-representative insurance schemes. In our study, we used French national administrative databases to analyse the 2010 prevalence and incidence rates of SLE on a nation-wide basis.

Methods:

The largest French health insurance scheme covers 88% of the population or 58,186,535 individuals. Patients with SLE were identified if they had full coverage for a chronic disease with a M32 code (ICD-10th) in the health insurance information system, or if they had a M32 code in the hospital discharge database in 2010.

Results:

Overall, 27,390 individuals were identified as having SLE, 88% were female. The crude 2010 prevalence of SLE was 47.1/100,000, and the WHO age-standardized rate 40.8/100,000. The crude 2010 annual incidence of SLE was 3.32 cases per 100,000 with peaks in females aged 30-39yo (9.11/100,000) and in males aged 50-59yo (1.78/100,000). Major differences in regional age-standardized prevalence rates were observed, with the lowest rates in the North-West metropolitan areas and the highest in Caribbean overseas areas, ranging from 26 to 118/100,000. 

Conclusion:

This is the largest nation-wide study of SLE population to date, based on 58 million beneficiaries of the French health insurance system. Variations in regional rates may reflect ethnic differences. Rates may be underestimated as beneficiaries may not request full coverage and may not be hospitalised for SLE. The prevalence and incidence rates may however provide useful guidance to improve SLE care.


Disclosure:

L. Arnaud,
None;

J. P. Fagot,
None;

M. Païta,
None;

A. Mathian,
None;

A. Fagot-Campagna,
None;

Z. Amoura,
None.

  • Tweet
  • Email
  • Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/incidence-and-prevalence-of-systemic-lupus-erythematosus-a-2010-nation-wide-population-based-study-using-french-national-administrative-databases/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology